Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MESOBLAST LTD Capital/Financing Update 2014

May 1, 2014

31658_rns_2014-05-01_542ad267-505c-45e0-b7c4-7df754dae7ef.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

Appendix 3B New issue announcement

Rule 2.7, 3.10.3, 3.10.4, 3.10.5

Appendix 3B

New issue announcement, application for quotation of additional securities and agreement

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 1/7/96. Origin: Appendix 5. Amended 1/7/98, 1/9/99, 1/7/2000, 30/9/2001, 11/3/2002, 1/1/2003, 24/10/2005.

Name of entity

MESOBLAST LIMITED

ABN

68 109 431 870

We (the entity) give ASX the following information.

Part 1 - All issues

You must complete the relevant sections (attach sheets if there is not enough space).

1
+Class of+securities issued or to be issued
2
Number of+securities issued or to be
issued (if known) or maximum number
which may be issued
3
Principal terms of the+securities (eg, if
options, exercise price and expiry date; if
partly
paid
+securities,
the
amount
outstanding and due dates for payment; if
+convertible securities, the conversion price
and dates for conversion)
Ordinary shares (fully paid) and Unlisted options to
acquire ordinaryshares
1. 293,400 Fully Paid Ordinary Shares
2. 200,000 Unlisted options to acquire ordinary
shares.
Ordinary Shares
293,400 Fully Paid Ordinary Shares as per the
company’s constitution, upon the exercise of
options.
Unlisted Options
200,000 Unlisted options to acquire ordinary shares at
a price per share of $6.79, vesting over three
years, and expiring 29 November 2018.
  • See chapter 19 for defined terms.

Appendix 3B Page 1

Appendix 3B New issue announcement

  • 4 Do the[+] securities rank equally in all respects from the date of allotment with an existing[+] class of quoted[+] securities?

If the additional securities do not rank equally, please state:

  • the date from which they do

  • the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment

  • the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment

  • 5 Issue price or consideration

  • 6 Purpose of the issue (If issued as consideration for the acquisition of assets, clearly identify those assets)

Yes for Ordinary Shares;
Ordinary Shares Issued Upon The Exercise of
Share Options:
Price per
Shares
Funds Received by the
Share
Issued
Company
$2.64
270,000
$712,800
$3.48
23,400
81,432
TOTAL
293,400
$794,232
200,000 Unlisted Options to Acquire Shares
Issued for No Consideration.
293,400 Ordinary shares issued upon the
exercise of options in accordance with
the
Company’s
Employee
Share
Ownership Plan.
200,000 Unlisted Options to Acquire Ordinary
Shares awarded to 1 senior employee
pursuant to the Company’s Employee
Share Ownership Plan. This award of
options forms part of the annual
remuneration packages of our senior
employees
located
outside
of
Australia.
  • See chapter 19 for defined terms.

Appendix 3B Page 2

Appendix 3B New issue announcement

7
Dates of entering+securities into uncertificated
holdings or despatch of certificates
Date
Registered
Number of Fully Paid
Shares Issued
23/12/2013
23,400
30/12/2013
270,000
Total
293,400
Date
Registered
Number of Unlisted
Options to Acquire Shares
Issued
14/01/2014
200,000
Total
200,000
Number
+Class
8
Number and+class of all+securitiesquotedon ASX (including
the securities in clause 2 if applicable)
321,616,694^
Ordinary Shares
Number
+Class
9
Number and+class of all+securities not quoted on ASX
(including_the securities in clause 2 if applicable)
12,719,608^^
Unlisted Options
10
Dividend policy (in the case of a trust, distribution policy) on the
increased capital (interests)
All ordinary shares rank equally
and participate in the
right
to
dividends
equally
^
_Ordinary Shares Balance per Appendix 3B lodged 20 Dec 13

Shares issued per Appendix 3B lodged 30 Apr 14
Shares issued per Appendix 3B lodged 01 May 14_
Number and +class of all +securitiesquotedon ASX
321,210,394
112,900
293,400
321,616,694
^^
Unlisted Options Balance per Appendix 3B lodged 20 Dec 13
Options issued per Appendix 3B lodged 30 Apr 14
Options exercised per Appendix 3B lodged 30 Apr 14
Options cancelled per Appendix 3B lodged 30 Apr 14
_Options issued per Appendix 3B lodged 01May 14

Options exercised per Appendix 3B lodged 01 May 14_
Number and +class of all +securitiesnot quotedon ASX
12,867,575
315,000
(112,900)
(256,667)
200,000
(293,400)
12,719,608
_

Shares/Options issued were omitted from items 2 to 7 in Appendix 3B
filed 30 April 2014 – however were disclosed as part of the balance
disclosed at items 8 and 9. This Appendix 3B (dated 01 May 2014)
provides the necessary disclosure in items 2 to 7 for these securities.
Date
Registered
Number of Fully Paid
Shares Issued
23/12/2013
23,400
30/12/2013
270,000
Total
293,400
Date
Registered
Number of Unlisted
Options to Acquire Shares
Issued
14/01/2014
200,000
Total
200,000
Date
Registered
Number of Fully Paid
Shares Issued
23/12/2013
23,400
30/12/2013
270,000
Total
293,400
Date
Registered
Number of Unlisted
Options to Acquire Shares
Issued
14/01/2014
200,000
Total
200,000
Date
Registered
Number of Fully Paid
Shares Issued
23/12/2013
23,400
30/12/2013
270,000
Total
293,400
Date
Registered
Number of Unlisted
Options to Acquire Shares
Issued
14/01/2014
200,000
Total
200,000
Number +Class
321,616,694^ Ordinary Shares
Number +Class

12,719,608^^
Unlisted Options

All ordinary shares rank equally
and participate in the
right
to
dividends
equally
321,210,394
112,900
293,400
321,616,694
12,867,575
315,000
(112,900)
(256,667)
200,000
(293,400)
12,719,608


  • See chapter 19 for defined terms.

Appendix 3B Page 3

Appendix 3B New issue announcement

Part 2 - Bonus issue or pro rata issue

11
Is
security
holder
approval
required?
12
Is the issue renounceable or non‐
renounceable?
13
Ratio in which the+securities
will be offered
14
+Class of+securities to which the
offer relates
15
+Record
date
to
determine
entitlements
16
Will
holdings
on
different
registers (or subregisters) be
aggregated
for
calculating
entitlements?
17
Policy for deciding entitlements
in relation to fractions
18
Names of countries in which the
entity has+security holders who
will not be sent new issue
documents
Note: Security holders must be told how their
entitlements are to be dealt with.
Cross reference: rule 7.7.
19
Closing
date
for
receipt
of
acceptances or renunciations
20
Names of any underwriters
21
Amount of any underwriting fee
or commission
22
Names of any brokers to the
issue
23
Fee or commission payable to
the broker to the issue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
  • See chapter 19 for defined terms.

Appendix 3B Page 4

Appendix 3B New issue announcement

24
Amount of any handling fee
payable to brokers who lodge
acceptances or renunciations on
behalf of+security holders
25
If the issue is contingent on
+security holders’ approval, the
date of the meeting
26
Date entitlement and acceptance
form and prospectus or Product
Disclosure Statement will be sent
to persons entitled
27
If the entity has issued options,
and the terms entitle option
holders
to
participate
on
exercise, the date on which
notices will be sent to option
holders
28
Date rights trading will begin (if
applicable)
29
Date rights trading will end (if
applicable)
30
How do+security holders sell
their entitlements_in full_through
a broker?
31
How do+security holders sell
part
of
their
entitlements
through a broker and accept for
the balance?
32
How do+security holders dispose
of their entitlements (except by
sale through a broker)?
33
+Despatch date
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
  • See chapter 19 for defined terms.

Appendix 3B Page 5

Appendix 3B New issue announcement

Part 3 - Quotation of securities

You need only complete this section if you are applying for quotation of securities

  • 34 Type of securities ( tick one )

  • (a)  Ordinary Shares Only as described in Part 1

  • (b) All other securities

Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities

Entities that have ticked box 34(a)

Additional securities forming a new class of securities

Tick to indicate you are providing the information or documents

35 If the[+] securities are[+] equity securities, the names of the 20 largest holders of the additional[+] securities, and the number and percentage of additional[+] securities held by those holders

36 If the[+] securities are[+] equity securities, a distribution schedule of the additional +securities setting out the number of holders in the categories 1 ‐ 1,000

1,001 ‐ 5,000 5,001 ‐ 10,000 10,001 ‐ 100,000 100,001 and over

37 A copy of any trust deed for the additional[+] securities

Entities that have ticked box 34(b)

38 Number of securities for which +quotation is sought 39 Class of +securities for which quotation is sought

  • See chapter 19 for defined terms.

Appendix 3B Page 6

Appendix 3B New issue announcement

40 Do the[+] securities rank equally in all respects from the date of allotment with an existing[+] class of quoted[+] securities?

If the additional securities do not rank equally, please state:

  • the date from which they do

  • the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment

  • the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment

41 Reason for request for quotation now

Example: In the case of restricted securities, end of restriction period (if issued upon conversion of another security, clearly identify that other security)

  • Number +Class

  • 42 Number and +class of all +securities quoted on ASX ( including the securities in clause 38)

  • See chapter 19 for defined terms.

Appendix 3B Page 7

Appendix 3B New issue announcement

Quotation agreement

  • 1 +Quotation of our additional +securities is in ASX’s absolute discretion. ASX may quote the[+] securities on any conditions it decides.

  • 2 We warrant the following to ASX.

  • The issue of the[+] securities to be quoted complies with the law and is not for an illegal purpose.

  • There is no reason why those[+] securities should not be granted +quotation.

  • An offer of the[+] securities for sale within 12 months after their issue will not require disclosure under section 707(3) or section 1012C(6) of the Corporations Act.

Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty

  • Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any[+] securities to be quoted and that no‐one has any right to return any[+] securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the[+] securities be quoted.

  • If we are a trust, we warrant that no person has the right to return the +securities to be quoted under section 1019B of the Corporations Act at the time that we request that the[+] securities be quoted.

  • 3 We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement.

  • 4 We give ASX the information and documents required by this form. If any information or document not available now, will give it to ASX before +quotation of the +securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete. Digitally signed by

==> picture [198 x 58] intentionally omitted <==

----- Start of picture text -----

Digitally signed by
[email protected]
DN:
[email protected]
om,
email=Jenni.Pilcher@mesobla
st.com
Date: 2014.05.01 19:52:47
+10'00'
Sign here: _______
Company Secretary
----- End of picture text -----

Date: 1st May 2014

Print name: Jenni Pilcher

  • See chapter 19 for defined terms.

Appendix 3B Page 8

Appendix 3B New issue announcement

Appendix 3B – Annexure 1

Calculation of placement capacity under rule 7.1 and rule 7.1A for eligible entities

Introduced 01/08/12 Amended 04/03/13

Part 1

Rule 7.1 – Issues exceeding 15% of capital

Step 1: Calculate “A”, the base figure from which the placement capacity is calculated

==> picture [415 x 383] intentionally omitted <==

----- Start of picture text -----

Insert number of fully paid [+] ordinary 315,423,901
securities on issue 12 months before the
+ issue date or date of agreement to issue
Add the following:
• Number of fully paid [+] ordinary securities 1,458,900
issued in that 12 month period under an
exception in rule 7.2
• Number of fully paid [+] ordinary securities
issued in that 12 month period with 0
shareholder approval
• Number of partly paid [+] ordinary 0
securities that became fully paid in that
12 month period
Note:
• Include only ordinary securities here –
other classes of equity securities cannot
be added
• Include here (if applicable) the securities
the subject of the Appendix 3B to which
this form is annexed
• It may be useful to set out issues of
securities on different dates as separate
line items
Subtract the number of fully paid [+] ordinary 0
securities cancelled during that 12 month
period
“A” 316,882,801
----- End of picture text -----

  • See chapter 19 for defined terms.

Appendix 3B Page 9

Appendix 3B New issue announcement

Step 2: Calculate 15% of “A”

“B” 0.15 [Note: this value cannot be changed] Multiply “A” by 0.15 47,532,420 Step 3: Calculate “C”, the amount of placement capacity under rule 7.1 that has already been used

  • Insert number of[+] equity securities issued 365,000 – Loan Funded Shares issued in or agreed to be issued in that 12 month the last 12 month period; and period not counting those issued: 3,018,893 – Fully Paid Shares issued for

  • • Under an exception in rule 7.2 purchase of assets as per Appendix 3B filed on 20 December 2013.

  • • Under rule 7.1A • With security holder approval under rule 7.1 or rule 7.4

  • Note: • This applies to equity securities, unless specifically excluded – not just ordinary securities

  • • Include here (if applicable) the securities the subject of the Appendix 3B to which this form is annexed

  • • It may be useful to set out issues of securities on different dates as separate line items

  • “C” 3,383,893

Step 4: Subtract “C” from [“A” x “B”] to calculate remaining placement capacity under rule 7.1

“A” x 0.15 47,532,420 Note: number must be same as shown in Step 2 Subtract “C” 3,383,893 Note: number must be same as shown in Step 3 Total [“A” x 0.15] – “C” 44,148,527 [Note: this is the remaining placement capacity under rule 7.1]

  • See chapter 19 for defined terms.

Appendix 3B Page 10

Appendix 3B New issue announcement

Part 2

New issue announcement
Part 2
New issue announcement
Part 2
Rule 7.1A – Additional placement capacity for eligible entities
Step 1: Calculate “A”, the base figure from which the placement
capacity is calculated
“A”
Note: number must be same as shown in
Step 1 of Part 1
Step 2: Calculate 10% of “A”
“D” 0.10
Note: this value cannot be changed
Multiply“A” by 0.10
Step 3: Calculate “E”, the amount of placement capacity under rule
7.1A that has already been used
Insertnumber of+equity securities issued
or agreed to be issued in that 12 month
period under rule 7.1A
Notes:
• This applies to equity securities – not
just ordinary securities
• Include here – if applicable – the
securities the subject of the Appendix
3B to which this form is annexed
• Do not include equity securities issued
under rule 7.1 (they must be dealt with
in Part 1), or for which specific security
holder approval has been obtained
• It may be useful to set out issues of
securities on different dates as separate
line items
“E”
  • See chapter 19 for defined terms.

Appendix 3B Page 11

Appendix 3B New issue announcement

Step 4: Subtract “E” from [“A” x “D”] to calculate remaining placement capacity under rule 7.1A

“A” x 0.10 Note: number must be same as shown in Step 2 Subtract “E” Note: number must be same as shown in Step 3 Total [“A” x 0.10] – “E” Note: this is the remaining placement capacity under rule 7.1A

  • See chapter 19 for defined terms.

Appendix 3B Page 12